Rebecca Araujo

DocwireNews

Treatment with radiation prior to chimeric antigen receptor (CAR) T-cell therapy was found to be safe and did not increase toxicity for patients with multiple myeloma (MM), according to new findings presented at the American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting.CAR-T therapy is an immunotherapy which uses genetically modified T-cells from the patient to reprogram their immune system to attack cancer cells. Radiation therapy is often used for patients with MM to alleviate bone pain, though the impact this treatment on patients receiving CAR-T cell therapy is still being studied.This new study found patients who received radiation 34 days or fewer before CAR-T infusions did not have higher rates severe of cytokine syndrome (CRS) or neurotoxicity than patients who did not receive the radiation bridging care, suggesting radiation is a safe option for patients prior to the cell therapy.Researchers from Penn Medicine conducted a retrospective analysis using medical records of 25 patients with MM who received CART-BCMA (B cell maturation antigen) cell therapy. Patients were categorized into three groups: those who received radiation t 34 days or less prior to CAR-T infusion, those who received radiation within one year of infusion, and a third group who received no radiation within at least one year preceding the cellular therapy.None of the four patients who underwent radiation within 34 days of CAR-T infusion experienced levels of CRS or other toxicities higher than grade 3. These patients also had lower rates of grade 4 hematologic toxicities. Three of eight patients who received radiation within one year of cellular therapy experienced grade 3 or higher CRS. Out of the 13 patients who did not receive any radiation therapy, five experienced grade 3 or higher CRS. Administration of radiation therapy was not associated with a decrease in overall survival or progression free survival.&ldquo;Our work is hypothesis generating, hinting at a potential synergism between radiation and CART-BCMA therapy, which has been reported by others in the literature,&rdquo; said lead author Shwetha Manjunath, MD, Radiation Oncology Resident at Penn&rsquo;s Perelman School of Medicine, in a <a href="https://www.eurekalert.org/pub_releases/2020-10/uops-pss102520.php">press release</a>. &ldquo;Future prospective trials that combine radiation with CART-BCMA may further optimize safety and long-term efficacy of this novel cell therapy.&rdquo;<blockquote class="twitter-tweet">
Penn Study supports use of radiation before CAR therapy for multiple myeloma | EurekAlert! Science News <a href="https://t.co/1F4dq04K94">https://t.co/1F4dq04K94</a>
&mdash; Majid Al Othman (@othmanmo) <a href="https://twitter.com/othmanmo/status/1320806247784976384?ref_src=twsrc%5Etfw">October 26, 2020</a>
</blockquote>

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Latest News

Radiation Prior to CAR-T Therapy for Multiple Myeloma Does Not Increase Toxicity

Oncology

Treatment with radiation prior to chimeric antigen receptor (CAR) T-cell therapy was found to be safe and did not increase toxicity for patients with multiple myeloma (MM), ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe